| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $35.1M | +22.7% | +0.9% |
| Cost of Revenue | $25.0M | +30.9% | +17.0% |
| R&D Expense | $2.6M | -4.9% | +226.0% |
| SG&A Expense | $4.6M | -21.9% | -42.6% |
| Operating Income | -$839K | +46.0% | -141.4% |
| Pre-tax Income | -$653K | +69.4% | -140.4% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.0M | +1.0% | -85.6% |
| Accounts Receivable | $14.4M | -7.6% | -13.4% |
| Inventory | $15.7M | -24.2% | -14.8% |
| Current Assets | $43.9M | -13.3% | -49.7% |
| Total Assets | $277.9M | -2.3% | -0.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $28K | — | — |
| Investing Cash Flow | -$7.8M | — | — |
| Financing Cash Flow | $1.1M | — | — |
| — |
| — |
| Net Income | -$653K | +69.4% | -140.4% |
| EPS (Basic) | -$0.02 | +60.0% | -150.0% |
| EPS (Diluted) | -$0.02 | +60.0% | -150.0% |
| $39.8M |
| -13.8% |
| +31.9% |
| Long-term Debt | $26.1M | -9.8% | +21.0% |
| Total Liabilities | $60.8M | -10.3% | -1.7% |
| Stockholders' Equity | $217.2M | +0.2% | -0.4% |